Clinical Trials Logo
  1. Home
  2. Healthy
  3. NCT04615611
  4. Details
NCT04615611 Clinical Trial

Physiologic Performance Response to Salbutamol

Healthy Clinical Trial

Official title:
Individual beta2-adrenergic Performance Response to Salbutamol

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04615611
Other study ID # SAL-POWER
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 7, 2020
Est. completion date November 7, 2021

Study information
Verified date October 2020
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project aims to investigate the individual physiological response to beta2-adrenergic stimulation with salbutamol on performance-related outcomes

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 20
Est. completion date November 7, 2021
Est. primary completion date November 7, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - 18 to 45 years of age - Trained individuals with maximal oxygen uptake above 55 mL/kg/min for men and 50 mL/kg/min for women - Body mass index lower than 26 Exclusion Criteria: - Allergy towards study drug - Unacceptable side effects of the study drug - Chronic disease deemed by the MD to impose a risk or severely confound the study outcomes - Current smokers - Use of prescription medicine - Pregnancy

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• salbutamol
inhalation of salbutamol
• Placebo
administration of placebo

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University of Copenhagen

Outcome
Type Measure Description Time frame Safety issue
Primary Sprint performance Power output during maximal cycling Measured ½ hour after drug administration
Secondary Muscle strength Quadriceps maximal voluntary contraction Measured ½ hour after drug administration
Secondary Sprint fatigue tolerance Fatigue index during maximal cycling Measured ½ hour after drug administration
Secondary Cycling endurance performance 4-min time trial on bike ergometer Measured ½ hour after drug administration
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1